Discussing Innovative Approaches in Gene Therapy for AMD by Targeting Inflammation, Establishing Retinal Bio-Factories as Long- Lasting Solutions
Time: 1:30 pm
day: Conference Day Two
Details:
- Exploring cutting-edge research in gene therapy targeting inflammatory pathways associated with the complement system dysregulation in AMD
- Discussing gene delivery vectors and viral vectors engineered to express therapeutic proteins locally in the retina, effectively turning it into a bio-factory
- Overcoming the challenge of frequent, invasive injections by developing long-lasting gene therapies as a once-and-done treatment for late-stage AMD
